|
When smokers puff a cigarette,
they often feel a sense of coolness and respite. But this
short term respite only leads to threatening affects to the
overall health such as lung diseases, cancer in the different
parts of body, impotence in men, peripheral vascular disease,
fertility problem in women, and coronary disease and heart
attack. And despite knowing all these extremely dangerous
risks, if you are still unable to stop nicotine craving, then
Chantix is the pill that will
not let you down. This new anti-smoking drug Chantix takes
a different approach to the problem of nicotine addiction.
It does what the nicotine gum and patches do, without their
nicotine.
The FDA has approved Chantix (varenicline tartrate) tablets for the treatment of smoking cessation - to help smokers give up smoking. Chantix, which works on specific parts of the brain, acts in a different way from nicotine-replacement therapies. In nicotine-replacement therapies, a small dose of nicotine is given with the motive to provide the smoker with this drug while the patient rise above the huge psychological and physical troubles that come while giving up smoking. But, Chantix lessens the withdrawal indications, which are very rigorous for some. It makes the patient produce more dopamine, which helps in lowering the cravings.
This quit smoking drug is a prescription drug made by Pfizer, earlier known as Champix, launched on 10 may, 2004. It was specially developed to make drug better than Zyban. Chantix should be taken for at least 12 weeks and could be continued for few more weeks if needed. The agency says it is committed to help smokers to do away with smoking.
Furthermore, Chantix's approval was based on a comprehensive clinical trial program including four pivotal trials involving more than 2,000 cigarette smokers. In a tryout, 1,900 smokers were put on a trial on Chantix. All of them took Chantix for the first 12 weeks, after which 1,236 (65%) were still not smoking. Then, the 1,236 quitters were then divided into two groups: One group continued taking Chantix while the other took other smoking cessation drug. This continued for another 12 weeks. At the end of the 24-week period, 70.5% of those on Chantix were not smoking and 49.6% of those on other drug were not smoking.
But on the other hand, Chantix side effects are also known that includes nausea, headaches, sleeping disorder/sleeplessness, abnormal dreams including nightmares, sleepiness and dizziness, gas, loss of taste and constipation. However, it is important to note that not all side effects happen in every person. Admittedly, many people suffer too much from the nausea to continue with the treatment but many of the other side effects are quite mild and potentially a small price to pay for quitting smoking. |
